BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1186/s12964-023-01319-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical Outcomes
- (2022) Dan Zheng et al. Frontiers in Pharmacology
- Cost–effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancer
- (2022) Min Huang et al. Immunotherapy
- BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
- (2021) Shuiyan Wu et al. Cancer Cell International
- Signaling pathways governing breast cancer stem cells behavior
- (2021) Kai Song et al. Stem Cell Research & Therapy
- BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell Carcinomas
- (2021) Matthew L. Fisher et al. CANCER RESEARCH
- PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
- (2020) Fatmah A. Mansour et al. OncoImmunology
- Regulation of sister chromatid cohesion by nuclear PD-L1
- (2020) Jia Yu et al. CELL RESEARCH
- Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy
- (2020) Jiyong Liang et al. Cancer Immunology Research
- Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer
- (2020) Yehui Shi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer
- (2020) Xin Jing et al. EXPERIMENTAL CELL RESEARCH
- CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
- (2020) María Auxiliadora Olivares-Urbano et al. Cells
- RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression
- (2020) Mei Wang et al. Cell Communication and Signaling
- Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
- (2020) Yang Gao et al. NATURE CELL BIOLOGY
- BRD4 regulates self‐renewal ability and tumorigenicity of glioma‐initiating cells by enrichment in the Notch1 promoter region
- (2020) Zhennan Tao et al. Clinical and Translational Medicine
- PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways
- (2019) Fang Wei et al. CANCER LETTERS
- Cancer stem cell self-renewal as a therapeutic target in human oral cancer
- (2019) Jinwei Hu et al. ONCOGENE
- A genome‐wide RNA i screen reveals essential therapeutic targets of breast cancer stem cells
- (2019) Abir Arfaoui et al. EMBO Molecular Medicine
- Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
- (2019) De Angelis et al. Cancers
- Inhibition of nuclear factor-κB p65 phosphorylation by 3,4-dihydroxybenzalacetone and caffeic acid phenethyl ester
- (2018) Ken Takakura et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells
- (2018) Norashikin Zakaria et al. Frontiers in Oncology
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- BRD4 and Cancer: going beyond transcriptional regulation
- (2018) Benedetta Donati et al. Molecular Cancer
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- The NF-κB Pathway and Cancer Stem Cells
- (2016) Amanda Rinkenbaugh et al. Cells
- Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance
- (2015) Ming Luo et al. CURRENT PHARMACEUTICAL DESIGN
- RELB Alters Proliferation of Human Pluripotent Stem Cells via IMP3- and LIN28-Mediated Modulation of the Expression of IGF2 and Other Cell-Cycle Regulators
- (2015) Nilay Yogeshkumar Thakar et al. STEM CELLS AND DEVELOPMENT
- Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors
- (2014) Daniel W. Beury et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- Genetic Susceptibility to Triple-Negative Breast Cancer
- (2013) K. N. Stevens et al. CANCER RESEARCH
- Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
- (2011) H. Korkaya et al. CLINICAL CANCER RESEARCH
- Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
- (2011) Shuet Theng Lee et al. MOLECULAR CELL
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now